Cardiovascular Drugs Market Opportunities, Research Report, Trends, Share, Regional Analysis by 2026

1
Cardiovascular Drugs Market Size, Share
Industry Analysis, By Drug Type
(Antihypertensive, Antihyperlipidemic,
Anticoagulants, Antiplatelet Drugs, Others), By
Disease Indication, By Distribution Channel
(Hospitals Pharmacies, Retail Pharmacies, Online
Pharmacies, Others) and Regional Forecast, 2019
-2026
Buy Now
Sample PDF
Get Discount
Published Date April 2019 Report Format PDF
Region Global Base Year 2018
2
Cardiovascular Drugs Market Size, Share
Industry Analysis, By Drug Type
(Antihypertensive, Antihyperlipidemic,
Anticoagulants, Antiplatelet Drugs, Others), By
Disease Indication, By Distribution Channel
(Hospitals Pharmacies, Retail Pharmacies, Online
Pharmacies, Others) and Regional Forecast, 2019
-2026
Report Highlights The global cardiovascular
drugs market size is set to touch USD 63.96
billion by 2026, exhibiting a CAGR of 3.8 during
the forecast period. Increasing incidence of
cardiovascular disorders will be one of the
central driving forces of growth for this market
in the next decade. According to the Global
Burden of Disease Study 2017, cardiovascular
disorder (CVD) is the most common chronic
disease, killing around 17.8 million people
annually. Of these, close to 82 of the deaths
occur in low and middle-income countries. The
World Health Organization (WHO) estimates that
80 of CVD deaths are caused by heart attack and
strokes. Fortune Business Insights, through its
report, titled Cardiovascular Drugs Market Size,
Share Industry Analysis, By Drug Type
(Antihypertensive, Antihyperlipidemic,
Anticoagulants, Antiplatelet Drugs, Others), By
Disease Indication (Hypertension, Hyperlipidemia,
Coronary Artery Disease, Arrhythmia, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019 -2026, brings out a
comprehensive analysis of the factors and
dynamics that are likely to influence the share,
size, and overall growth of the market during the
forecast period.
3
Cardiovascular Drugs Market Size, Share
Industry Analysis, By Drug Type
(Antihypertensive, Antihyperlipidemic,
Anticoagulants, Antiplatelet Drugs, Others), By
Disease Indication, By Distribution Channel
(Hospitals Pharmacies, Retail Pharmacies, Online
Pharmacies, Others) and Regional Forecast, 2019
-2026
Rising Demand for Effective Treatment Drugs to
Stir Innovation One of the leading cardiovascular
drugs market trends is the steady spread of
awareness about the effects of CVDs. This is
causing an upsurge in the demand for CVD drugs, a
need that is being bolstered by rising pollution
levels and an increasingly sedentary lifestyle.
The response from the industry has been positive
as many companies are coming out novel drugs to
cure such conditions as effectively as possible.
For instance, Bristol-Myers Squibb and Pfizer
jointly developed Eliquis, a low-risk
cardiovascular drug that was rapidly adopted by
patients and doctors alike. These developments
are expected to vastly enhance the potential of
this market in the near future. High Incidence
Rate of Risk Factors to Fuel the Market in North
America North America generated a revenue of USD
21.89 billion in 2018 and is anticipated to
continue its dominance of the cardiovascular
drugs market share in the forecast period. The
main factors driving the market include
increasing prevalence of risk factors such as
obesity and diabetes that are associated with
cardiovascular conditions, presence of large
companies, and growing incidence of CVDs in the
region. Browse Complete Report
Details https//www.fortunebusinessinsights.com/i
ndustry-reports/cardiovascular-therapeutics-market
-100379
4
Cardiovascular Drugs Market Size, Share
Industry Analysis, By Drug Type
(Antihypertensive, Antihyperlipidemic,
Anticoagulants, Antiplatelet Drugs, Others), By
Disease Indication, By Distribution Channel
(Hospitals Pharmacies, Retail Pharmacies, Online
Pharmacies, Others) and Regional Forecast, 2019
-2026

• List of the companies functioning in the global
  market are
• Merck Co., Inc.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Janssen Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• Bayer AG
• Novartis AG
• Gilead Sciences, Inc.
• AstraZeneca
• Request a Sample Copy of Research Report
• https//www.fortunebusinessinsights.com/enquiry/re
  quest-sample-pdf/cardiovascular-therapeutics-marke
  t-100379
•  

5
Cardiovascular Drugs Market Size, Share
Industry Analysis, By Drug Type
(Antihypertensive, Antihyperlipidemic,
Anticoagulants, Antiplatelet Drugs, Others), By
Disease Indication, By Distribution Channel
(Hospitals Pharmacies, Retail Pharmacies, Online
Pharmacies, Others) and Regional Forecast, 2019
-2026
About Us Fortune Business Insights offers expert
corporate analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them to address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence, giving
a granular overview of the market they are
operating in.    Our reports contain a unique mix
of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our
team of experienced analysts and consultants use
industry-leading research tools and techniques to
compile comprehensive market studies,
interspersed with relevant data.    Phone US 1
424 253 0390 UK 44 2071 939123 APAC 91 744
740 1245 Email sales_at_fortunebusinessinsights.com